MarginsXMarginsX
Home › Markets › Health Care › ADVB

Advanced Biomed Inc. (ADVB)

ADVB trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.22
-12.25% on the day
Market cap
$3.7M
Nano cap
Revenue · 2026
$128K
No prior year to compare
Net income · 2026
$6.7M
5231.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1941029/000121390026109029/0001213900-26-109029-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.

Profile

FieldValue
TickerADVB on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryTaiwan
IPO year2025
SEC CIK0001941029
SEC industry codeServices-Medical Laboratories
Incorporated inNV

Financials · 2026

LineValue
Revenue$128K
Net income$6.7M
Operating income-$6.2M
Net margin5231.3%
Operating margin-4883.8%
Revenue growthNo prior-year revenue to compare
Cash$386K
Total assets$13.8M
P/E (computed)0.5×
P/S (computed)28.7×

Warning signs

Cash runway
1.7 months
$214K cash at September 30, 2026
Share count, 1 year
+52.7%
2025-11-19 to 2026-11-12
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$214K cash; operating cash flow -$377K a quarter.Report 2026-09-30
Shares outstanding1,652,133 (2026-11-12); 21,640,000 a year earlier. 1y figure adjusted for split (1-for-20 overall).Cover page 2026-11-12
Reverse splits, 3 years1; latest 1-for-20 on 2026-02-20Source 2026-02-20
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-21
AuditorWWC, P.C., San Mateo, California, United StatesPCAOB Form AP 2026-10-15
Late filings, 12 months1 NT noticeNT 10-K 2026-09-28
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-09-30
Not filed-$989K-$171K$214KNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2026
2026-06-30
Not filed$695K-$583K$386KNo debt tags$128K10-K 2026-10-13
Q3 2026
2026-03-31
Not filed-$489K-$240K$2.6MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q2 2026
2025-12-31
Not filed$6.9M-$514K$2.6MNo debt tagsNeeds four quarters10-Q 2026-02-13
Q1 2026
2025-09-30
Not filed-$387K-$610K$13KNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-06-30
Not filed-$702K-$1.5M$31KNo debt tagsNeeds four quarters10-K 2026-10-13
Q3 2025
2025-03-31
Not filed-$1.4M-$3.4M$3.2MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q2 2025
2024-12-31
Not filed-$908K-$842K$2.6MNo debt tagsNeeds four quarters10-Q 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-12025-07-23
Latest annual report
ANNUAL REPORT
10-K2026-10-13
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-07-17
Latest proxy
DEFINITIVE PROXY STATEMENT
DEF 14A2026-06-04

Source: SEC EDGAR submissions feed, 99 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+27.8%
1 month-51.0%
3 months-70.5%
Year to date-56.7%
1 year-71.8%
From 52-week high-86.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ACONAclarion Inc.$1.39-12.58%$4.0M
BGLCBioNexus Gene Lab Corp$0.8200-0.12%$2.4M
ACHAccendra Health Inc.$0.0857-35.08%$6.6M
AMSAmerican Shared Hospital Services$1.07-0.93%$7.1M
MDXHMDxHealth SA$0.1490+3.40%$14.2M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
XGNExagen Inc.$3.77-8.72%$96.2M
BDSXBiodesix Inc.$9.00-8.91%$99.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier